Taking it to the street
Results 11 - 20 of 516 : Previous 1 2 3 4 5 6 7 8 9 Next
5-Star ETFs Poised to Pop: SPDR S&P Biotech
Market-trouncing returns could be written in this five-star.
FDA Irony: Less Data, Longer Review
Poor Onyx Pharma.
How Cheap Is Celgene's Stock by the Numbers?
Let's take a look.
Why Amgen's Earnings Are Outstanding
All cash flow is not created equal.
Gilead Sciences Passes This Key Test
Look here for a clue.
One Reason the Street Should Love Biogen Idec's Earnings
Don't just count the cash. Time it.
The Highest-Rated Biopharma Stocks
These stocks were given the highest marks in their industry by our community of investors.
Here's How Amgen May Be Failing You
Keep your eye on margins.
Celgene to Pump $45M Into Quanticel to Discover Cancer Drugs
Celgene strikes an unusual agreement.
Check out the cash king margin.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK